Leuprolide Market Report

Global Leuprolide Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：146
  • REPORT CODE：GMM865935
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Leuprolide market report explains the definition, types, applications, major countries, and major players of the Leuprolide market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Beijing Boente Pharmaceutical

    • Daewoong

    • Chong Kun Dang

    • Leadiant Biosciences

    • Hikma Pharmaceuticals

    • Teva

    • Hanall

    • AbbVie

    • Selleck

    • Livzon Pharmaceutical

    • Sandoz (Novartis)

    • SciAnda Pharma

    • Lee Pharma

    • Chengdu Shenguo Biological Pharmaceutical

    • Enteris BioPharma

    • GP Pharm

    • Bayer

    • Sanofi

    • Sun Pharmaceutical

    • TOLMAR PHARMACEUTICALS

    • Hangzhou Peptide Biochemical

    • Takeda

    By Type:

    • Subcutaneous

    • Topical

    By End-User:

    • Breast Cancer

    • Endometriosis

    • Precocious Puberty

    • Prostate Cancer

    • Uterine Fibrosis

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Leuprolide Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Leuprolide Outlook to 2028- Original Forecasts

    • 2.2 Leuprolide Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Leuprolide Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Leuprolide Market- Recent Developments

    • 6.1 Leuprolide Market News and Developments

    • 6.2 Leuprolide Market Deals Landscape

    7 Leuprolide Raw Materials and Cost Structure Analysis

    • 7.1 Leuprolide Key Raw Materials

    • 7.2 Leuprolide Price Trend of Key Raw Materials

    • 7.3 Leuprolide Key Suppliers of Raw Materials

    • 7.4 Leuprolide Market Concentration Rate of Raw Materials

    • 7.5 Leuprolide Cost Structure Analysis

      • 7.5.1 Leuprolide Raw Materials Analysis

      • 7.5.2 Leuprolide Labor Cost Analysis

      • 7.5.3 Leuprolide Manufacturing Expenses Analysis

    8 Global Leuprolide Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Leuprolide Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Leuprolide Export by Region (Top 10 Countries) (2017-2028)

    9 Global Leuprolide Market Outlook by Types and Applications to 2022

    • 9.1 Global Leuprolide Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Subcutaneous Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Topical Consumption and Growth Rate (2017-2022)

    • 9.2 Global Leuprolide Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Endometriosis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Precocious Puberty Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Uterine Fibrosis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Leuprolide Market Analysis and Outlook till 2022

    • 10.1 Global Leuprolide Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Leuprolide Consumption (2017-2022)

      • 10.2.2 Canada Leuprolide Consumption (2017-2022)

      • 10.2.3 Mexico Leuprolide Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Leuprolide Consumption (2017-2022)

      • 10.3.2 UK Leuprolide Consumption (2017-2022)

      • 10.3.3 Spain Leuprolide Consumption (2017-2022)

      • 10.3.4 Belgium Leuprolide Consumption (2017-2022)

      • 10.3.5 France Leuprolide Consumption (2017-2022)

      • 10.3.6 Italy Leuprolide Consumption (2017-2022)

      • 10.3.7 Denmark Leuprolide Consumption (2017-2022)

      • 10.3.8 Finland Leuprolide Consumption (2017-2022)

      • 10.3.9 Norway Leuprolide Consumption (2017-2022)

      • 10.3.10 Sweden Leuprolide Consumption (2017-2022)

      • 10.3.11 Poland Leuprolide Consumption (2017-2022)

      • 10.3.12 Russia Leuprolide Consumption (2017-2022)

      • 10.3.13 Turkey Leuprolide Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Leuprolide Consumption (2017-2022)

      • 10.4.2 Japan Leuprolide Consumption (2017-2022)

      • 10.4.3 India Leuprolide Consumption (2017-2022)

      • 10.4.4 South Korea Leuprolide Consumption (2017-2022)

      • 10.4.5 Pakistan Leuprolide Consumption (2017-2022)

      • 10.4.6 Bangladesh Leuprolide Consumption (2017-2022)

      • 10.4.7 Indonesia Leuprolide Consumption (2017-2022)

      • 10.4.8 Thailand Leuprolide Consumption (2017-2022)

      • 10.4.9 Singapore Leuprolide Consumption (2017-2022)

      • 10.4.10 Malaysia Leuprolide Consumption (2017-2022)

      • 10.4.11 Philippines Leuprolide Consumption (2017-2022)

      • 10.4.12 Vietnam Leuprolide Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Leuprolide Consumption (2017-2022)

      • 10.5.2 Colombia Leuprolide Consumption (2017-2022)

      • 10.5.3 Chile Leuprolide Consumption (2017-2022)

      • 10.5.4 Argentina Leuprolide Consumption (2017-2022)

      • 10.5.5 Venezuela Leuprolide Consumption (2017-2022)

      • 10.5.6 Peru Leuprolide Consumption (2017-2022)

      • 10.5.7 Puerto Rico Leuprolide Consumption (2017-2022)

      • 10.5.8 Ecuador Leuprolide Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Leuprolide Consumption (2017-2022)

      • 10.6.2 Kuwait Leuprolide Consumption (2017-2022)

      • 10.6.3 Oman Leuprolide Consumption (2017-2022)

      • 10.6.4 Qatar Leuprolide Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Leuprolide Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Leuprolide Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Leuprolide Consumption (2017-2022)

      • 10.7.2 South Africa Leuprolide Consumption (2017-2022)

      • 10.7.3 Egypt Leuprolide Consumption (2017-2022)

      • 10.7.4 Algeria Leuprolide Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Leuprolide Consumption (2017-2022)

      • 10.8.2 New Zealand Leuprolide Consumption (2017-2022)

    11 Global Leuprolide Competitive Analysis

    • 11.1 Beijing Boente Pharmaceutical

      • 11.1.1 Beijing Boente Pharmaceutical Company Details

      • 11.1.2 Beijing Boente Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Beijing Boente Pharmaceutical Leuprolide Main Business and Markets Served

      • 11.1.4 Beijing Boente Pharmaceutical Leuprolide Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Daewoong

      • 11.2.1 Daewoong Company Details

      • 11.2.2 Daewoong Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Daewoong Leuprolide Main Business and Markets Served

      • 11.2.4 Daewoong Leuprolide Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Chong Kun Dang

      • 11.3.1 Chong Kun Dang Company Details

      • 11.3.2 Chong Kun Dang Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Chong Kun Dang Leuprolide Main Business and Markets Served

      • 11.3.4 Chong Kun Dang Leuprolide Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Leadiant Biosciences

      • 11.4.1 Leadiant Biosciences Company Details

      • 11.4.2 Leadiant Biosciences Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Leadiant Biosciences Leuprolide Main Business and Markets Served

      • 11.4.4 Leadiant Biosciences Leuprolide Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Hikma Pharmaceuticals

      • 11.5.1 Hikma Pharmaceuticals Company Details

      • 11.5.2 Hikma Pharmaceuticals Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Hikma Pharmaceuticals Leuprolide Main Business and Markets Served

      • 11.5.4 Hikma Pharmaceuticals Leuprolide Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Teva

      • 11.6.1 Teva Company Details

      • 11.6.2 Teva Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Teva Leuprolide Main Business and Markets Served

      • 11.6.4 Teva Leuprolide Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hanall

      • 11.7.1 Hanall Company Details

      • 11.7.2 Hanall Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hanall Leuprolide Main Business and Markets Served

      • 11.7.4 Hanall Leuprolide Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 AbbVie

      • 11.8.1 AbbVie Company Details

      • 11.8.2 AbbVie Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 AbbVie Leuprolide Main Business and Markets Served

      • 11.8.4 AbbVie Leuprolide Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Selleck

      • 11.9.1 Selleck Company Details

      • 11.9.2 Selleck Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Selleck Leuprolide Main Business and Markets Served

      • 11.9.4 Selleck Leuprolide Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Livzon Pharmaceutical

      • 11.10.1 Livzon Pharmaceutical Company Details

      • 11.10.2 Livzon Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Livzon Pharmaceutical Leuprolide Main Business and Markets Served

      • 11.10.4 Livzon Pharmaceutical Leuprolide Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Sandoz (Novartis)

      • 11.11.1 Sandoz (Novartis) Company Details

      • 11.11.2 Sandoz (Novartis) Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Sandoz (Novartis) Leuprolide Main Business and Markets Served

      • 11.11.4 Sandoz (Novartis) Leuprolide Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 SciAnda Pharma

      • 11.12.1 SciAnda Pharma Company Details

      • 11.12.2 SciAnda Pharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 SciAnda Pharma Leuprolide Main Business and Markets Served

      • 11.12.4 SciAnda Pharma Leuprolide Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Lee Pharma

      • 11.13.1 Lee Pharma Company Details

      • 11.13.2 Lee Pharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Lee Pharma Leuprolide Main Business and Markets Served

      • 11.13.4 Lee Pharma Leuprolide Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Chengdu Shenguo Biological Pharmaceutical

      • 11.14.1 Chengdu Shenguo Biological Pharmaceutical Company Details

      • 11.14.2 Chengdu Shenguo Biological Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Main Business and Markets Served

      • 11.14.4 Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Enteris BioPharma

      • 11.15.1 Enteris BioPharma Company Details

      • 11.15.2 Enteris BioPharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Enteris BioPharma Leuprolide Main Business and Markets Served

      • 11.15.4 Enteris BioPharma Leuprolide Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 GP Pharm

      • 11.16.1 GP Pharm Company Details

      • 11.16.2 GP Pharm Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 GP Pharm Leuprolide Main Business and Markets Served

      • 11.16.4 GP Pharm Leuprolide Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Bayer

      • 11.17.1 Bayer Company Details

      • 11.17.2 Bayer Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Bayer Leuprolide Main Business and Markets Served

      • 11.17.4 Bayer Leuprolide Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Sanofi

      • 11.18.1 Sanofi Company Details

      • 11.18.2 Sanofi Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Sanofi Leuprolide Main Business and Markets Served

      • 11.18.4 Sanofi Leuprolide Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Sun Pharmaceutical

      • 11.19.1 Sun Pharmaceutical Company Details

      • 11.19.2 Sun Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Sun Pharmaceutical Leuprolide Main Business and Markets Served

      • 11.19.4 Sun Pharmaceutical Leuprolide Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 TOLMAR PHARMACEUTICALS

      • 11.20.1 TOLMAR PHARMACEUTICALS Company Details

      • 11.20.2 TOLMAR PHARMACEUTICALS Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 TOLMAR PHARMACEUTICALS Leuprolide Main Business and Markets Served

      • 11.20.4 TOLMAR PHARMACEUTICALS Leuprolide Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Hangzhou Peptide Biochemical

      • 11.21.1 Hangzhou Peptide Biochemical Company Details

      • 11.21.2 Hangzhou Peptide Biochemical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Hangzhou Peptide Biochemical Leuprolide Main Business and Markets Served

      • 11.21.4 Hangzhou Peptide Biochemical Leuprolide Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Takeda

      • 11.22.1 Takeda Company Details

      • 11.22.2 Takeda Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Takeda Leuprolide Main Business and Markets Served

      • 11.22.4 Takeda Leuprolide Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    12 Global Leuprolide Market Outlook by Types and Applications to 2028

    • 12.1 Global Leuprolide Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Topical Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Leuprolide Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Endometriosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Precocious Puberty Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Uterine Fibrosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Leuprolide Market Analysis and Outlook to 2028

    • 13.1 Global Leuprolide Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Leuprolide Consumption Forecast (2022-2028)

      • 13.2.2 Canada Leuprolide Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Leuprolide Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Leuprolide Consumption Forecast (2022-2028)

      • 13.3.2 UK Leuprolide Consumption Forecast (2022-2028)

      • 13.3.3 Spain Leuprolide Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Leuprolide Consumption Forecast (2022-2028)

      • 13.3.5 France Leuprolide Consumption Forecast (2022-2028)

      • 13.3.6 Italy Leuprolide Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Leuprolide Consumption Forecast (2022-2028)

      • 13.3.8 Finland Leuprolide Consumption Forecast (2022-2028)

      • 13.3.9 Norway Leuprolide Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Leuprolide Consumption Forecast (2022-2028)

      • 13.3.11 Poland Leuprolide Consumption Forecast (2022-2028)

      • 13.3.12 Russia Leuprolide Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Leuprolide Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Leuprolide Consumption Forecast (2022-2028)

      • 13.4.2 Japan Leuprolide Consumption Forecast (2022-2028)

      • 13.4.3 India Leuprolide Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Leuprolide Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Leuprolide Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Leuprolide Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Leuprolide Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Leuprolide Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Leuprolide Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Leuprolide Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Leuprolide Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Leuprolide Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Leuprolide Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Leuprolide Consumption Forecast (2022-2028)

      • 13.5.3 Chile Leuprolide Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Leuprolide Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Leuprolide Consumption Forecast (2022-2028)

      • 13.5.6 Peru Leuprolide Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Leuprolide Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Leuprolide Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Leuprolide Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Leuprolide Consumption Forecast (2022-2028)

      • 13.6.3 Oman Leuprolide Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Leuprolide Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Leuprolide Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Leuprolide Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Leuprolide Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Leuprolide Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Leuprolide Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Leuprolide Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Leuprolide Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Leuprolide Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Leuprolide

    • Figure of Leuprolide Picture

    • Table Global Leuprolide Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Leuprolide Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure Global Precocious Puberty Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Uterine Fibrosis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Leuprolide Consumption by Country (2017-2022)

    • Table North America Leuprolide Consumption by Country (2017-2022)

    • Figure United States Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Canada Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Mexico Leuprolide Consumption and Growth Rate (2017-2022)

    • Table Europe Leuprolide Consumption by Country (2017-2022)

    • Figure Germany Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure UK Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Spain Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Belgium Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure France Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Italy Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Denmark Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Finland Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Norway Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Sweden Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Poland Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Russia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Turkey Leuprolide Consumption and Growth Rate (2017-2022)

    • Table APAC Leuprolide Consumption by Country (2017-2022)

    • Figure China Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Japan Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure India Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure South Korea Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Thailand Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Singapore Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Philippines Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Leuprolide Consumption and Growth Rate (2017-2022)

    • Table South America Leuprolide Consumption by Country (2017-2022)

    • Figure Brazil Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Colombia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Chile Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Argentina Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Peru Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Leuprolide Consumption and Growth Rate (2017-2022)

    • Table GCC Leuprolide Consumption by Country (2017-2022)

    • Figure Bahrain Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Oman Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Qatar Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Leuprolide Consumption and Growth Rate (2017-2022)

    • Table Africa Leuprolide Consumption by Country (2017-2022)

    • Figure Nigeria Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure South Africa Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Egypt Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Algeria Leuprolide Consumption and Growth Rate (2017-2022)

    • Table Oceania Leuprolide Consumption by Country (2017-2022)

    • Figure Australia Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Leuprolide Consumption and Growth Rate (2017-2022)

    • Table Beijing Boente Pharmaceutical Company Details

    • Table Beijing Boente Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Boente Pharmaceutical Leuprolide Main Business and Markets Served

    • Table Beijing Boente Pharmaceutical Leuprolide Product Portfolio

    • Table Daewoong Company Details

    • Table Daewoong Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daewoong Leuprolide Main Business and Markets Served

    • Table Daewoong Leuprolide Product Portfolio

    • Table Chong Kun Dang Company Details

    • Table Chong Kun Dang Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chong Kun Dang Leuprolide Main Business and Markets Served

    • Table Chong Kun Dang Leuprolide Product Portfolio

    • Table Leadiant Biosciences Company Details

    • Table Leadiant Biosciences Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Leadiant Biosciences Leuprolide Main Business and Markets Served

    • Table Leadiant Biosciences Leuprolide Product Portfolio

    • Table Hikma Pharmaceuticals Company Details

    • Table Hikma Pharmaceuticals Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Pharmaceuticals Leuprolide Main Business and Markets Served

    • Table Hikma Pharmaceuticals Leuprolide Product Portfolio

    • Table Teva Company Details

    • Table Teva Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Leuprolide Main Business and Markets Served

    • Table Teva Leuprolide Product Portfolio

    • Table Hanall Company Details

    • Table Hanall Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hanall Leuprolide Main Business and Markets Served

    • Table Hanall Leuprolide Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Leuprolide Main Business and Markets Served

    • Table AbbVie Leuprolide Product Portfolio

    • Table Selleck Company Details

    • Table Selleck Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Selleck Leuprolide Main Business and Markets Served

    • Table Selleck Leuprolide Product Portfolio

    • Table Livzon Pharmaceutical Company Details

    • Table Livzon Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Pharmaceutical Leuprolide Main Business and Markets Served

    • Table Livzon Pharmaceutical Leuprolide Product Portfolio

    • Table Sandoz (Novartis) Company Details

    • Table Sandoz (Novartis) Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz (Novartis) Leuprolide Main Business and Markets Served

    • Table Sandoz (Novartis) Leuprolide Product Portfolio

    • Table SciAnda Pharma Company Details

    • Table SciAnda Pharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table SciAnda Pharma Leuprolide Main Business and Markets Served

    • Table SciAnda Pharma Leuprolide Product Portfolio

    • Table Lee Pharma Company Details

    • Table Lee Pharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lee Pharma Leuprolide Main Business and Markets Served

    • Table Lee Pharma Leuprolide Product Portfolio

    • Table Chengdu Shenguo Biological Pharmaceutical Company Details

    • Table Chengdu Shenguo Biological Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Shenguo Biological Pharmaceutical Leuprolide Main Business and Markets Served

    • Table Chengdu Shenguo Biological Pharmaceutical Leuprolide Product Portfolio

    • Table Enteris BioPharma Company Details

    • Table Enteris BioPharma Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enteris BioPharma Leuprolide Main Business and Markets Served

    • Table Enteris BioPharma Leuprolide Product Portfolio

    • Table GP Pharm Company Details

    • Table GP Pharm Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table GP Pharm Leuprolide Main Business and Markets Served

    • Table GP Pharm Leuprolide Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Leuprolide Main Business and Markets Served

    • Table Bayer Leuprolide Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Leuprolide Main Business and Markets Served

    • Table Sanofi Leuprolide Product Portfolio

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Leuprolide Main Business and Markets Served

    • Table Sun Pharmaceutical Leuprolide Product Portfolio

    • Table TOLMAR PHARMACEUTICALS Company Details

    • Table TOLMAR PHARMACEUTICALS Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table TOLMAR PHARMACEUTICALS Leuprolide Main Business and Markets Served

    • Table TOLMAR PHARMACEUTICALS Leuprolide Product Portfolio

    • Table Hangzhou Peptide Biochemical Company Details

    • Table Hangzhou Peptide Biochemical Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hangzhou Peptide Biochemical Leuprolide Main Business and Markets Served

    • Table Hangzhou Peptide Biochemical Leuprolide Product Portfolio

    • Table Takeda Company Details

    • Table Takeda Leuprolide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Leuprolide Main Business and Markets Served

    • Table Takeda Leuprolide Product Portfolio

    • Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Precocious Puberty Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Uterine Fibrosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leuprolide Consumption Forecast by Country (2022-2028)

    • Table North America Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure United States Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure Germany Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure China Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure Brazil Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Leuprolide Consumption Forecast by Country (2022-2028)

    • Figure Australia Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Leuprolide Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US